{"DataElement":{"publicId":"2431568","version":"1","preferredName":"Cutaneous Melanoma Positive Surgical Margin Neoplasm Present NCI Concept Code","preferredDefinition":"Indicates the degree of invasiveness of neoplasm at the positive cutaneous melanoma margin.","longName":"2431362v1.0:2433699v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431362","version":"1","preferredName":"Cutaneous Melanoma Positive Surgical Margin Neoplasm","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.:definition pending_An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"2431286v1.0:2431212v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431286","version":"1","preferredName":"Cutaneous Melanoma Positive Surgical Margin","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.:definition pending","longName":"C3510:C48620","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Surgical Margin","conceptCode":"C48620","definition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF331-A20A-3B35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431212","version":"1","preferredName":"Neoplasm","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE203-C860-3264-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE049E-8CC0-422E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2433699","version":"1","preferredName":"Cutaneous Melanoma Positive Surgical Margin Neoplasm Present NCI Concept Code","preferredDefinition":"Indicates what neoplasm is present at margin._A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"2433699v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Invasive Melanoma","valueDescription":"Invasive Melanoma","ValueMeaning":{"publicId":"2577134","version":"1","preferredName":"Invasive Melanoma","longName":"2577134","preferredDefinition":"Invasive Melanoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Cutaneous Melanoma","conceptCode":"C48607","definition":"A melanoma of the skin that is not confined to the dermal-epidermal junction, and has infiltrated the dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA5B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"SBREXT","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06BB6599-428B-21F1-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-29","modifiedBy":"ONEDATA","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"Melanoma in Situ","valueDescription":"Stage 0 Skin Melanoma","ValueMeaning":{"publicId":"2580715","version":"1","preferredName":"Stage 0 Skin Melanoma","longName":"2580715","preferredDefinition":"A melanoma of the skin characterized by the presence of melanoma cells in the dermal-epidermal junction only, without infiltration of the papillary or reticular dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C8423","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Melanoma in situ.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0858-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-08-31","modifiedBy":"CURTIST","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C52B9DF-6B0B-6625-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-08-31","modifiedBy":"CURTIST","dateModified":"2006-08-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433292","version":"1","preferredName":"NCI Concept Code","preferredDefinition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"C43516","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI Concept Code","conceptCode":"C43516","definition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"062A6784-EC8C-6CFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-22","modifiedBy":"ONEDATA","dateModified":"2005-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06459C26-C280-6BA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CHILLIJ","dateModified":"2014-03-31","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley; added CAP CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812064","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.cutaneousMelanoma","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.upmc.opi.cabig.caties.cap.domain.cutaneousMelanoma.CutaneousMelanomaPositiveSurgicalMargin.neoplasmPresent","type":"UML Qualified Attr","context":"NCIP"},{"name":"CutaneousMelanomaPositiveSurgicalMargin:neoplasmPresent","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Present at margin","type":"Preferred Question Text","description":"Present at margin","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE5BD8-5050-5C3C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"CHILLIJ","dateModified":"2014-03-31","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}